TM Editors’ Note: This article discusses a penny stock/microcap. Such stocks are easily manipulated; do your own careful due diligence. It is very rare that we write about the uranium market. A while back, we concluded that uranium could be setting up for a breakout, although it eventually refused to do so. So far, we do not…
Here are my charts of GDX and GLD during pre-market trading today (Thursday, March 31st). I sent this chart to my followers alerting them of today’s market bias and intraday trade setup. If you don’t know what spike alerts are, let me explain briefly. In short, the market gives of these rogue price spikes which…
Confusion and delay ultimately have a price to pay. That’s the case whether it is the perpetuating of a ‘bad news is good news’ monetary policy of low rates for an infinite period of time, or whether it’s a lack of cohesive strategies to engage terrorists in Europe, ‘as if’ it’s still early enough to…
USDJPY: With the pair halting its weakness on two rejection candles, it now looks to recover higher. On the downside, support comes in at the 112.00 level where a break if seen will aim at the 111.50 level. A cut through here will turn focus to the 111.00 level and possibly lower towards the 110.50…
General Motors (GM) has set sights on producing more than 9.8 million vehicles in 2016 and exceeding the record it set in 2015. From the fundamental baseline, GM is strong and growing stronger. Its core business dynamics are excellent. The price to earnings ratio is a reasonable 5.25, and experts have rated the stock as a buy for…
Many, even the brightest and experienced investors, believe central banks and/or their agents, have been manipulating equity markets for the past nearly eight years. Japan for example makes no bones about buying domestic shares on the open market. The Swiss Central Bank has also admitted doing likewise. There are others including scattered European member ECB…
Shares of Genocea Biosciences (GNCA) closed up 94% today after this morning’s announcement of achieving positive phase 2 results in patients with genital herpes. This phase 2 trial used the company’s vaccine known as GEN-003 to treat these patients over a 12-month period. The vaccine showed that it was able to obtain statistically significant reductions…
Calculated “inflation” in Europe disappointed again in March, as for the second month in a row the HICP rate was below zero. There had been some hope after the German version turned just slightly positive that it would herald a different sign for the rest of Europe. Instead, inflation rates in other places were mostly…
The second half of 2015 was a bit challenging, but the year has seen a decent overall performance by the Finance sector. While the near-term earnings projection remains dismal, the sector is not expected to disappoint investors in the quarters ahead. This is because, the sector’s performance majorly dependents on the nation’s economic health which…
Shares of irrigation systems manufacturer Lindsay (LNN) are plunging after the company reported second quarter results that missed on the top and bottom lines. Lindsay’s commentary on the farming economy is sending other stocks in the agriculture sector lower. WHAT’S NEW: Lindsay reported a loss of (37c) on revenue of $120.6M, both lower than analysts…
